Pandemic Response Strains Global Biopharmaceutical Reactor Capacity

Distress grows as manufacturers wait for suppliers to boost production. One idea: stretch inventories by qualifying single-use bioreactors for reuse.

COVID-19 vaccine manufacturing
Coronavirus vaccines get first priority for bioreactors • Source: Alamy

More from Cell & Gene Therapies

More from Advanced Technologies